[Childhood and adolescent depression].

Area of Science:

• Child and Adolescent Psychiatry
• Mental Health Research
• Clinical Psychology

Background:

• Depression is a prevalent, chronic, and recurring condition in children and adolescents.
• Major Depressive Disorder (MDD) significantly impacts the well-being of young individuals.
• Understanding the epidemiology, clinical presentation, and natural history of pediatric depression is crucial.

Purpose of the Study:

• To review the epidemiology, clinical characteristics, natural course, and treatment options for MDD in children and adolescents.
• To evaluate the efficacy of pharmacological and psychotherapeutic interventions for pediatric depression.
• To identify challenges and research needs for MDD treatment in Japan.

Main Methods:

• Systematic review of randomized controlled trials (RCTs) on MDD treatments in youth.
• Analysis of existing literature on the effectiveness of selective serotonin reuptake inhibitors (SSRIs) and psychotherapy.
• Examination of the current treatment landscape and availability of interventions in Japan.

Main Results:

• Selective serotonin reuptake inhibitors (SSRIs), particularly fluoxetine, demonstrate efficacy in treating pediatric MDD.
• Psychotherapeutic approaches, including cognitive behavioral therapy (CBT) and interpersonal therapy (IPT), are effective for youth depression.
• Limited availability of SSRIs and trained psychotherapists in Japan poses a barrier to optimal care.

Conclusions:

• SSRIs and psychotherapy are established, effective treatments for major depressive disorder in children and adolescents.
• Significant gaps exist in Japan regarding the availability and accessibility of evidence-based treatments for pediatric depression.
• Further clinical research is imperative to improve treatment outcomes for young individuals with MDD in Japan.